Answers are grounded in this paper and cite their sources.
Augmented reality (AR) is increasingly used as a phygital touchpoint for introducing new products, yet its effectiveness in facilitating new product adoption remains unclear. Across four studies, we show that AR-based product presentation influences purchase intention through outcome-oriented mental simulation, which reflects consumers' consideration of the anticipated benefits and final utility of product use. This effect depends on product innovativeness. For really new products, AR-based presentation increases outcome simulation and purchase intention because consumers need greater support to understand and imagine unfamiliar product outcomes. In contrast, for incrementally new products, AR-based presentation decreases both responses, as consumers can more readily infer product outcomes from existing category knowledge. These findings identify AR-based presentation as an early-stage, information-oriented phygital touchpoint, extend AR research by highlighting its information-disclosure function, and show that firms should deploy AR selectively according to the innovativeness of the product being introduced.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: